Experts from Germany, Italy, the UK and Brussels will talk about strategies to overcome barriers to the potential billion dollar market for cannabidiol (CBD) at a one-day workshop planned Sept. 17 in Germany.
The session, entitled “CBD (cannabidiol) as a food additive, body care and pharmaceutical – effects, production, authorization and legislation,” will take place in the Cologne-Bonn Airport, and will run from 10 a.m. to 4:30 p.m. The event is organized by the nova Institute with support of the European Industrial Hemp Association. Registration is required.
Featured presenters for the workshop are:
Daniel Kruse, CEO at HempConsult GmbH, Dusseldorf and an EIHA board member. He is a senior advisor to entrepreneurs, startups, investors and other industry stakeholders. Kruse, who has been in the hemp industry since 1995, is also CEO at Hempro GmbH & Co. KG.
Lorenza Romanese, Managing Director, EIHA, a veteran policy advisor and communication manager at the European level. She has led EIHA’s efforts in Brussels since February 2019, and has worked with a number MEPs to propose hemp reforms to the European Union’s Common Agriculture Policy.
Joscha Krauss, CEO at MH medical hemp GmbH, Germany, an EIHA member which makes CBD and a line of CBD-infused cosmetics. He is active worldwide in the areas of medicinal cannabis and CBD.
Catherine Wilson, CannaWell (UK), who is also an EIHA Board Member.
While new markets are already emerging in North America, Israel, Asia and Latin America, Europe is still struggling to regulate CBD so that safe and legal products find their customers. Among key challenges to the sector are recent changes in the Novel Foods Catalogue that threaten to make certain hemp foods and extracts more expensive to get to market, and THC levels allowable in European hemp.
